Patients with AR+ BrM had a numerically longer median time from diagnosis of breast cancer to diagnosis of BrM, compared to those with AR− BrM, although this was not statistically significant (51 vs. 29 months, p = 0.16) (Figure 4c). Here, AR is linked to breast cancer.